EULAR Management of Rheumatoid Arthritis with Disease-Modifying Antirheumatic Drugs

Clinical Guideline InSights · Apr 2, 2026 · 2m

The 2026 EULAR guideline on Management of Rheumatoid Arthritis with Synthetic and Biologic Disease-Modifying Antirheumatic Drugs, summarizing key recommendations on DMARD therapy, treatment targets, and more.

Management of Rheumatoid Arthritis with Synthetic and Biologic Disease-Modifying Antirheumatic Drugs

European League Against Rheumatism (EULAR)

March 13 2026

Guideline Summary: https://www.guidelinecentral.com/guideline/5135295

Full-Text: https://ard.eular.org/article/S0003-4967(26)00075-0/fulltext